L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial

Abstract

While these data are preliminary and need confirmation they indicate that patients with pancreatic cancer may have a clinically relevant benefit from the inexpensive and well tolerated oral supplementation of L-Carnitine.